WBC to disregard UKAD suspension of Rodriguez for PEDs

Compiled by Scott Shaffer

04/04/2026

WBC to disregard UKAD suspension of Rodriguez for PEDs

Despite a two-year suspension from the United Kingdom Anti-Doping (UKAD) handed out to Mexican flyweight Francisco Rodriguez Jr., the WBC will continue to allow Rodriguez to compete in WBC bouts. The WBC stripped Rodriguez of his interim title last year following a positive test for an illegal substance after a fight against Gala Yafai, but in a new ruling, the WBC accepted Rodriguez's explanation that the banned substance came from a sports drink. Here is the WBC's ruling:
 
On July 8, 2025, the Voluntary Anti-Doping Association (“VADA”) notified Francisco “Chihuas” Rodriguez, Jr. and the WBC that the urine sample collected from him on June 21, 2025, in Birmingham, United Kingdom, in connection with his bout for the interim WBC flyweight championship against Galal Yafai, yielded an adverse analytical finding for Heptaminol (the “Adverse Finding”). Heptaminol is a known cardiac stimulant and vasodilator. Heptaminol is a metabolite of Octodrine. It is also a banned substance. On July 11, 2025, the WBC CBP Results Management Unit notified then-Champion Rodriguez of the Adverse Finding and of the start of its investigation of the circumstances that led to it. Soon after receiving the notification, Rodriguez’s representatives provided photographic evidence of a container and label of an energy enhancement supplement called Lipodrene. There is ample scientific literature support for the fact that supplements containing stimulants have also been found to include and/or be contaminated with Octodrine and other banned substances.
 
Rodriguez admitted to unintentionally ingesting a supplement that was likely contaminated with Octodrine. A significant extenuating fact is that Rodriguez reported the use of Lipodrene to the WBC CBP on his registration form. Therefore, in the view of the WBC, his consumption of Lipodrene was not an intentional or knowing ingestion of a banned substance with the purpose of enhancing his athletic performance.
 
The WBC and Rodriguez therefore entered into an Adjudication Agreement which: (a) placed him on probation for one year from the date of the sample collection; (b) vacated his WBC interim title; (c) changed the outcome of his victory against Galal Yafai to a No Contest; and (d) ordered a minimum of three random VADA anti-doping tests at Rodriguez’s sole cost during the probationary period. Three anti-doping tests have been conducted and all have yielded negative results.
 
Rodriguez has also participated in social responsibility events and he and his camp cooperated with the WBC CBP at all stages of the investigation of his adverse finding. He has complied with all conditions in the Adjudication Agreement.
 
The WBC has learned that on March 30th, UK Anti-Doping (UKAD) notified Rodriguez that it had imposed a two-year period of ineligibility for the very same adverse finding described above.
 
The WBC legal counsel as well as the WBC CBP Results Management Unit have tried several times in prior cases to work together with UKAD in situations similar to Rodriguez’s. UKAD has never responded to the WBC’s overtures and does not recognize the WBC CBP nor its results management rulings or Adjudication Agreements.
 
The Rodriguez vs. Yafai bout took place under the authority of the WBC [as well as the British Board of Boxing Control]. In light of the WBC/Rodriguez fair and just Adjudication Agreement, the WBC will continue to allow Rodriguez to compete in WBC bouts.
 
PRIOR BOXINGTALK COVERAGE
 
MARCH 30, 2026: According to UKAD, Mexican flyweight Francisco Rodriguez Jr. has been banned from all World Anti-Doping Code-compliant sports competitions for two years, following Anti-Doping Rule Violations (ADRVs) for the presence and use of prohibited substances.  On June 21, 2025, UKAD collected a urine sample from Rodriguez, after his bout against Galal Yafai in Birmingham, England. Analysis of the sample returned an Adverse Analytical Finding (AAFs) for the prohibited substances octodrine and its metabolite, heptaminol, in addition to an AAF for oxilofrine. Octodrine, heptaminol and oxilofrine are specified substances that are prohibited in-competition only. The problem here is that Rodriguez won the Yafai bout by unanimous decision, making him the WBC interim champion at the time. The WBC has given Yafai the interim title but still ranks Rodriguez as the #1 contender. Rodriguez won another fight in Mexico in October.
 
UKAD notified Rodriguez of his adverse analytical findings and imposed a provisional suspension. Having received no response to the notice, UKAD subsequently charged him with both ADRVs. Still, Rodriguez provided UKAD with no response to the charge, despite multiple efforts to contact the boxer across various channels.  UKAD did not assert that the ADRVs were intentional and imposed a two-year period of Ineligibility. The ban is deemed to have begun on July 30th 2025 (the date of the provisional suspension) and will expire on July 29, 2027